Q2 2017 13F Holders as of 30 Jun 2017
-
Type / Class
-
Equity / Ordinary Shares, nominal value Euro 0.04 per share
-
Shares outstanding
-
105,365,368
-
Total 13F shares
-
9,002,972
-
Share change
-
+376,677
-
Total reported value
-
$46,815,000
-
Price per share
-
$5.20
-
Number of holders
-
17
-
Value change
-
+$1,971,549
-
Number of buys
-
8
-
Number of sells
-
5
Institutional Holders of ProQR Therapeutics N.V. - Ordinary Shares, nominal value Euro 0.04 per share (PRQR) as of Q2 2017
As of 30 Jun 2017 ProQR Therapeutics N.V. - Ordinary Shares, nominal value Euro 0.04 per share (PRQR) had 17 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 9,002,972 shares of stock of the company.
Largest 10 holders included JENNISON ASSOCIATES LLC, ORBIMED ADVISORS LLC, Redmile Group, LLC, Clearbridge Investments, LLC, Artal Group S.A., JANUS HENDERSON GROUP PLC, SPHERA FUNDS MANAGEMENT LTD., FRANKLIN RESOURCES INC, FMR LLC, and ALTRINSIC GLOBAL ADVISORS LLC.
This table shows 17 institutional shareholders of the security as of 30 Jun 2017.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.